UBC Medical Indonesia Tbk. vs Wahana Ottomitra Multiartha Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Wahana Ottomitra Multiartha Tbk. trades at Rp254 (market cap 863.41B, 35.5K 24h volume). The key difference: Wahana Ottomitra Multiartha Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 35.5K). Which is the better fit depends on your goals.
| LABS | WOMF | |
|---|---|---|
Market Cap | 576.7B | 863.41B |
Volume | 3.48M | 35.5K |
Lot | 34.82K | 355 |
Turnover | 522.79M | 8.95M |
Average Price | 150.13 | 252.2 |
Value | 522.79M | 8.95M |
Indicative Equilibrium Price | 148 | 254 |
Indicative Equilibrium Volume | 350 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Wahana Ottomitra Multiartha Tbk (the Company) formerly PT Jakarta Tokyo Leasing, was established based on notarial deed No.179 dated March 23, 1982 of Kartini Muljadi SH, notary in Jakarta. The name was changed to PT Fuji Semeru Leasing on Dec 15 1982 and changed to PT Wahana Ometraco Multiartha on March 15, 2000. On November 30, 2004, the Company obtained the Effective Letter of the Registration Statement for the Initial Public Offering of Shares from the Chairman of the Capital Market Supervisory Agency (BAPEPAM) in its Letter No.S-3551/PM/2004. The Companys shares were listed on the Jakarta and Surabaya Stock Exchange (now Indonesia Stock Exchange) on December 13, 2004.
Read more on WOMF →